For the fourth module in the Going Global program, we welcome visiting international expert Dr Caroline Popper, co-founder and President of Popper and Company.
Caroline founded Popper and Company with Ken Walz more than fifteen years ago to address inefficiencies in healthcare by helping life science companies develop and commercialize new technology. Today, the members of their growing team leverage their extensive knowledge of the tools and trends shaping all aspects of healthcare market and impacting its participants.
She has managed a wide spectrum of diagnostics, device and drug discovery businesses in both Fortune 500 and start-up settings, at amongst others, Becton Dickinson, bioMerieux, and MDS. Now, at her firm, Caroline combines those experiences with her clinical experience to help clients interpret relevant market forces, develop strategies and create partnerships to thrive in the global changing, and increasingly value-driven, healthcare landscape.
This module has three components:
BioBriefing: Cutting-edge trends in the US healthcare market: Commercial strategy and the need to adapt
Tuesday 16 October – Registration at 3.45pm, presentation & discussion 4.00pm – 5:00pm, followed by networking until 6.00pm
Venue: PriceWaterhouse Coopers, Level 19, 2 Riverside Quay, Southbank
The medical device and life sciences industries move at a fast pace with major advances in technology and exponential market growth markedly pronounced in some geographies. The evolution of healthcare innovation occurs in a global market context, where binding forces such as evolving politics, reforming policies and, increasingly, shifts in consumer demand drive market growth and influence change.
In this BioBriefing, learn about cutting-edge trends in the healthcare market, how best to anticipate change in market movements, and how this might be distilled to inform go-to-market commercial strategy for healthcare enterprises.
If you are unable to participate in the full module, you can register to just attend the module BioBriefing.
Workshop: US commercial strategy development: Creating global appeal
Wednesday 17 October – 8.45am – 5.00pm
Venue: West Tower Suite, Level 35, Sofitel on Collins, 25 Collins Street, Melbourne
This workshop will provide attendees with an in-depth look at the key considerations for ‘healthtech’ companies looking to enter the US market. Discussions will cover topics including customer segments; key competitors in each industry subcategory; a crash course on reimbursement and payment considerations; distribution channels; and creating a US-centric strategy that has global appeal.
Though particular emphasis will be on the interests of medical device and diagnostics companies, pharmaceutical and digital health will also be discussed.
A 30-minute advisory session with Caroline
Meetings will be held on Thursday 18 and Friday 19 October – We will contact you to arrange a suitable time for your 30-minute meeting. You are not required outside of this time on these two days.
Venue: BioMelbourne Network, 25 Flinders Lane, Melbourne
Registration for each module includes:
The fee is $550 (incl. GST) for your first Going Global module, then $440 (incl. GST) for any subsequent module(s).
Registration confirmation: Please note that places are strictly limited and registration is subject to confirmation by BioMelbourne Network.
Cancellation policy: A full refund is given up to 14 days prior to the module. No refunds within 14 days of the module.